Colloidal stability and degradability of silica nanoparticles in biological fluids: A review
A da Cruz Schneid, LJC Albuquerque… - Journal of Sol-Gel …, 2022 - Springer
This review shows the most common and promising strategies to generate colloidally stable
silica nanoparticles (NPs) in simulated biological fluids and sheds light on the latest …
silica nanoparticles (NPs) in simulated biological fluids and sheds light on the latest …
Donor–acceptor materials exhibiting deep blue emission and thermally activated delayed fluorescence with tris (triazolo) triazine
Five luminescent donor–acceptor compounds based on the tris (triazolo) triazine (TTT)
acceptor were prepared. Out of the series of emitters, TTT-3HMAT exhibits deep blue …
acceptor were prepared. Out of the series of emitters, TTT-3HMAT exhibits deep blue …
Organic nanoparticle tracking during pharmacokinetic studies
S Bonnet, R Elfatairi, F Franconi, E Roger… - Nanomedicine, 2021 - Taylor & Francis
To understand how nanoparticles (NPs) interact with biological barriers and to ensure they
maintain their integrity over time, it is crucial to study their in vivo pharmacokinetic (PK) …
maintain their integrity over time, it is crucial to study their in vivo pharmacokinetic (PK) …
Silica nanoparticles decorated with gadolinium oxide nanoparticles for magnetic resonance and optical imaging of tumors
J Yin, X Wang, H Zheng, J Zhang, H Qu… - ACS Applied Nano …, 2021 - ACS Publications
We report a type of core@ dotted-shell structured nanoprobe that incorporates water-soluble
silica and water-interacted gadolinium oxide, endowed with excellent hydrophilicity and high …
silica and water-interacted gadolinium oxide, endowed with excellent hydrophilicity and high …
[HTML][HTML] Dynamic light scattering unveils stochastic degradation in large-pore mesoporous silica nanoparticles
V Guerrero-Florez, A Barbara, S Kodjikian… - Journal of Colloid and …, 2024 - Elsevier
Abstract Mesoporous Silica Nanoparticles (MSNs) have been increasingly investigated as
versatile drug delivery carriers. A particular challenge for the systemic use of MSNs lies in …
versatile drug delivery carriers. A particular challenge for the systemic use of MSNs lies in …